• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions.中东和中亚国家的药品市场与卫生系统：政策与行动创新变革之时
Arch Med Sci. 2011 Jun;7(3):365-7. doi: 10.5114/aoms.2011.23397. Epub 2011 Jul 11.
2
Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study.疾病负担指标与领先制药公司的创新：一项全球和区域比较研究。
Global Health. 2020 Sep 10;16(1):80. doi: 10.1186/s12992-020-00610-2.
3
National and local antibiotic policies in Central and Eastern Europe.中东欧国家和地方的抗生素政策。
J Chemother. 2000 Dec;12(6):471-4. doi: 10.1179/joc.2000.12.6.471.
4
Examining the temporal impact of stock market development on carbon intensity: Evidence from South Asian countries.考察股票市场发展对碳强度的时变影响：来自南亚国家的证据。
J Environ Manage. 2021 Nov 1;297:113248. doi: 10.1016/j.jenvman.2021.113248. Epub 2021 Jul 27.
5
Innovations in health services delivery from transition economies in Eastern Europe and Central Asia.东欧和中亚转型经济体的卫生服务提供创新。
Health Aff (Millwood). 2009 Jul-Aug;28(4):1011-21. doi: 10.1377/hlthaff.28.4.1011.
6
Antibiotic policies in Central/Eastern Europe (CEE) after 1990.
J Hosp Infect. 1999 Dec;43 Suppl:S269-74. doi: 10.1016/s0195-6701(99)90098-1.
7
A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.一种新方法来收集药品市场数据以支持政策实施和药品可及性：以赞比亚的抗疟药品为例。
Malar J. 2018 Nov 29;17(1):444. doi: 10.1186/s12936-018-2594-9.
8
The impact of the legal regime of intellectual property protection in the pharmaceutical market.知识产权保护法律制度对药品市场的影响。
Wiad Lek. 2016;69(3 pt 2):582-586.
9
Criteria to assess potential reverse innovations: opportunities for shared learning between high- and low-income countries.评估潜在逆向创新的标准：高收入国家和低收入国家之间共享学习的机会。
Global Health. 2017 Jan 25;13(1):4. doi: 10.1186/s12992-016-0225-1.
10
The impact of the legal regime of intellectual property protection in the pharmaceutical market.知识产权保护法律制度对药品市场的影响。
Wiad Lek. 2016;69(3 pt 2):582-586.

引用本文的文献

1
Challenge of Politico-Economic Sanctions on Pharmaceutical Procurement in Iran: A Qualitative Study.政治经济制裁对伊朗药品采购的挑战：定性研究。
Iran J Med Sci. 2022 Mar;47(2):152-161. doi: 10.30476/IJMS.2021.89901.2078.
2
Trend Analysis of Medicine Consumption Based on Therapeutic Categories in Iran: 2000-2016.基于治疗类别的伊朗药品消费趋势分析：2000 - 2016年
J Res Pharm Pract. 2018 Apr-Jun;7(2):95-103. doi: 10.4103/jrpp.JRPP_17_96.
3
Assessment of Household Disposal of Pharmaceuticals in Lebanon: Management Options to Protect Water Quality and Public Health.黎巴嫩家庭药品处置情况评估：保护水质和公众健康的管理方案
Environ Manage. 2016 May;57(5):1125-37. doi: 10.1007/s00267-016-0666-6. Epub 2016 Feb 5.
4
A news media analysis of economic sanction effects on access to medicine in Iran.一则关于经济制裁对伊朗药品可及性影响的新闻媒体分析。
J Res Pharm Pract. 2015 Oct-Dec;4(4):199-205. doi: 10.4103/2279-042X.167042.
5
Consistent defined threshold and equity in health.健康方面一致的既定阈值与公平性。
Daru. 2015 Feb 10;23(1):12. doi: 10.1186/s40199-015-0097-6.
6
A system dynamics model for national drug policy.国家药物政策的系统动力学模型。
Daru. 2014 Apr 1;22(1):34. doi: 10.1186/2008-2231-22-34.
7
Code of ethics for the national pharmaceutical system: Codifying and compilation.国家制药系统道德规范：编纂与汇编。
J Res Med Sci. 2013 May;18(5):442-8.
8
Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children.添加新型抗癫痫药物与传统方案联用控制儿童难治性癫痫的成本效益分析。
Daru. 2012 Aug 30;20(1):17. doi: 10.1186/2008-2231-20-17.
9
Biosimilars; a unique opportunity for Iran national health sector and national pharmaceutical industry.生物类似药；伊朗国家卫生部门和国家制药行业的独特机遇。
Daru. 2012 Sep 10;20(1):35. doi: 10.1186/2008-2231-20-35.
10
Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?德黑兰（伊朗）私人药店的财务视角；这是一个有利可图的生意吗？
Daru. 2012 Oct 22;20(1):62. doi: 10.1186/2008-2231-20-62.

本文引用的文献

1
The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis.抗生素在肠易激综合征治疗中的地位：系统评价和荟萃分析。
Arch Med Sci. 2010 Mar 1;6(1):49-55. doi: 10.5114/aoms.2010.13507. Epub 2010 Mar 9.
2
World Kidney Day 2011 - Protect your kidneys, save your heart.2011年世界肾脏日——保护肾脏，拯救心脏。
Arch Med Sci. 2011 Feb;7(1):1-4. doi: 10.5114/aoms.2011.20596. Epub 2011 Mar 8.
3
Patterns of antibiotic consumption in Iran during 2000-2009.2000年至2009年伊朗的抗生素消费模式。
Int J Antimicrob Agents. 2011 May;37(5):489-90. doi: 10.1016/j.ijantimicag.2011.01.022. Epub 2011 Mar 17.
4
Pharmaceutical expenditure, total health-care expenditure and GDP.药品支出、医疗保健总支出与国内生产总值
Health Econ. 2008 Oct;17(10):1187-206. doi: 10.1002/hec.1317.
5
Health indicators and human development in the Arab region.阿拉伯地区的健康指标与人类发展
Int J Health Geogr. 2006 Dec 28;5:61. doi: 10.1186/1476-072X-5-61.
6
Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran.国家药物政策（NDP）及其标准化指标的监测；符合伊朗国家药品遴选委员会的决定。
BMC Int Health Hum Rights. 2005 May 10;5(1):5. doi: 10.1186/1472-698X-5-5.
7
International comparisons of health care expenditures: what we know and what we do not know.医疗保健支出的国际比较：我们知道什么以及我们不知道什么。
J Health Serv Res Policy. 1999 Apr;4(2):122-6. doi: 10.1177/135581969900400211.

Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions.

作者信息

Abdollahias Akbar, Nikfar Shekoufeh, Abdollahi Mohammad

机构信息

Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.

出版信息

Arch Med Sci. 2011 Jun;7(3):365-7. doi: 10.5114/aoms.2011.23397. Epub 2011 Jul 11.

DOI:10.5114/aoms.2011.23397
PMID:22295018
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3258741/
Abstract
摘要